Qatar Biomedical Research Institute Qatar
Dr Mohammed Dehbi obtained his M.Sc. degree in molecular and cellular biology from Université Louis Pasteur, France in 1988. In 1995, he obtained his Ph.D. in biochemistry from l’Université de Montreal, Canada and conducted postdoctoral training at McGill University, Canada. In 1997, he joined Targanta Therapeutics, which is a Montreal-based bio-pharmaceutical company focusing on developing new classes of antibiotics based on phage genomics. He was later promoted in recognition of his major achievements.
Metabolomics:Open Access received 895 citations as per Google Scholar report
Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi 